Reports for TEVA CANADA LIMITED
Company Name
TEVA CANADA LIMITED
Totals |
||
Shortage reports |
3192 |
|
| Actual shortage: | 254 (8%) | |
| Anticipated shortage: | 1 (0%) | |
| Avoided shortage: | 10 (0%) | |
| Resolved: | 2927 (92%) | |
Discontinuation Reports |
435 |
|
| To be discontinued: | 2 (0%) | |
| Discontinued: | 410 (94%) | |
| Reversed: | 23 (5%) | |
Late reports |
482 (13%) |
|
Overdue reports |
11 (4%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-ROPINIROLE | 0.25MG | TABLET | Resolved | 2020-08-27 | 2020-11-12 | 123081 |
| TEVA-ROPINIROLE | 1MG | TABLET | Resolved | 2020-09-11 | 2021-01-07 | 124095 |
| TEVA-ROPINIROLE | 2MG | TABLET | Resolved | 2020-09-24 | 2020-11-12 | 125004 |
| TEVA-ROPINIROLE | 5MG | TABLET | Resolved | 2021-04-01 | 2024-05-30 | 136751 |
| TEVA-ROPINIROLE | 1MG | TABLET | Resolved | 2021-07-08 | 2023-09-22 | 142175 |
| TEVA-ROPINIROLE | 2MG | TABLET | Resolved | 2021-07-08 | 2023-09-24 | 142178 |
| TEVA-ROPINIROLE | 1MG | TABLET | Resolved | 2021-07-15 | 2021-07-15 | 142578 |
| TEVA-ROPINIROLE | 2MG | TABLET | Avoided shortage | 2021-07-15 | 2021-07-15 | 142581 |
| TEVA-ROPINIROLE | 0.25MG | TABLET | Resolved | 2021-08-27 | 2023-06-09 | 144682 |
| TEVA-ROPINIROLE | 0.25MG | TABLET | Resolved | 2023-06-26 | 2023-08-18 | 196471 |
| TEVA-ROPINIROLE | 0.25MG | TABLET | Resolved | 2024-02-08 | 2024-10-11 | 218977 |
| TEVA-ROPINIROLE | 0.25MG | TABLET | Resolved | 2025-04-24 | 2025-11-13 | 255709 |
| TEVA-ROPINIROLE | 2MG | TABLET | Resolved | 2025-07-18 | 2025-11-13 | 263152 |
| TEVA-ROPINIROLE | 5MG | TABLET | Resolved | 2025-07-18 | 2025-11-13 | 263155 |
| TEVA-ROPINIROLE | 1MG | TABLET | Resolved | 2025-10-10 | 2025-11-13 | 269235 |
| TEVA-ROSUVASTATIN | 20MG | TABLET | Resolved | 2019-06-18 | 2019-11-21 | 86914 |
| TEVA-ROSUVASTATIN | 20MG | TABLET | Resolved | 2019-06-18 | 2019-11-21 | 86917 |
| TEVA-ROSUVASTATIN | 20MG | TABLET | Resolved | 2019-06-18 | 2019-11-21 | 86920 |
| TEVA-ROSUVASTATIN | 40MG | TABLET | Resolved | 2019-08-22 | 2019-09-19 | 92157 |
| TEVA-ROSUVASTATIN | 10MG | TABLET | Resolved | 2019-10-17 | 2019-12-19 | 96717 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-PREGABALIN | 75MG | CAPSULE | Discontinued | 2020-07-10 | 2020-07-10 | 120033 |
| TEVA-PREGABALIN | 225MG | CAPSULE | Discontinued | 2025-05-28 | 2025-05-28 | 258622 |
| TEVA-PREGABALIN | 150MG | CAPSULE | Discontinued | 2025-05-28 | 2025-05-28 | 258627 |
| TEVA-PREGABALIN | 25MG | CAPSULE | Discontinued | 2025-05-28 | 2025-05-28 | 258631 |
| TEVA-PREGABALIN | 300MG | CAPSULE | Discontinued | 2025-05-28 | 2025-05-28 | 258756 |
| TEVA-PROCTOSONE | 1% 1% 0.5% 0.5% | OINTMENT | Discontinued | 2025-04-25 | 2025-04-25 | 255840 |
| TEVA-PROFEN | 600MG | TABLET | Discontinued | 2025-05-28 | 2025-05-28 | 258499 |
| TEVA-PROGESTERONE | 100MG | CAPSULE | Reversed | 2025-05-28 | 2025-06-20 | 258574 |
| TEVA-QUETIAPINE | 100MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 64846 |
| TEVA-QUETIAPINE | 25MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 64849 |
| TEVA-QUETIAPINE | 100MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 65036 |
| TEVA-QUETIAPINE | 200MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 65039 |
| TEVA-QUETIAPINE | 25MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 65044 |
| TEVA-QUETIAPINE | 300MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 65047 |
| TEVA-QUININE | 300MG | CAPSULE | Discontinued | 2020-01-24 | 2020-01-24 | 104294 |
| TEVA-QUININE | 200MG | CAPSULE | Discontinued | 2020-10-08 | 2020-10-09 | 125976 |
| TEVA-RABEPRAZOLE EC | 20MG | TABLET (DELAYED-RELEASE) | Discontinued | 2020-07-10 | 2020-07-10 | 120015 |
| TEVA-RABEPRAZOLE EC | 10MG | TABLET (DELAYED-RELEASE) | Discontinued | 2020-07-10 | 2020-07-10 | 120018 |
| TEVA-RANITIDINE | Discontinued | 2020-02-13 | 2020-02-13 | 106136 | ||
| TEVA-RANITIDINE | Discontinued | 2020-02-13 | 2020-02-13 | 106139 |